Treating stress urinary incontinence by tissue engineering – Nature Reviews Bioengineering

We thank all team members of MUVON Therapeutics for their expertise and personal achievements in each of the topics mentioned, while translating an academic process towards a commercial one. We also thank M. Graf for his input on the literature search and T. Haralampieva, N. Schwarz and J. Hegetschweiler for graphic design. We acknowledge funding and support from Horizon2020 for the phase 1 trial, and Wyss Zurich Translational Center and University of Zurich for the phase 2 study.